Amelot Holdings Announces Appointment of Top Tier Strategies Firm of Washington, D.C.
June 29 2009 - 8:42AM
Marketwired
Amelot Holdings, Inc. (PINKSHEETS: AMHD) announced that as part of
its continuing corporate development strategy, it has engaged David
E. Price, Esq. of Washington, D.C. to work alongside its current
corporate attorney and Company's Secretary Andrew L. Schwab, Esq.
Mr. Price specializes in corporate law and securities matters,
specifically in small to medium capitalized companies. He is the
principal of Top Tier, a boutique niche of corporate attorneys,
financial and equity analysts. Messrs. Price and Schwab will be
working closely over the next 90 days to upgrade the Company's
transparency through updating its public listing information, full
submission of records to auditors and other such steps as they deem
necessary to create a favorable environment for return on equity
investments in the Company.
For more information on David E. Price, Esq., please go to
www.TopTierStrategies.com
About Amelot Holdings, Inc. (PINKSHEETS: AMHD):
Amelot Holdings, Inc. (http://www.amelotholdings.com), a
publicly traded company, is a diversified holding company that has
identified Biodiesel as a multi-billion-dollar emerging Biofuel
market. Amelot plans to have a significant market share in growing
low cost feedstocks to supply the growing demand for biodiesel, to
reduce energy dependency of fossil fuels, to help reduce the U.S.
dependency on foreign oil supplies and reduce the impact of energy
on our environment.
Statements in this press release that are not historical facts
are forward-looking statements within the meaning of the Securities
Act of 1933, as amended. Those statements include statements
regarding the intent, belief or current expectations of the Company
and its management. Such statements reflect management's current
views, are based on certain assumptions and involve risks and
uncertainties. Actual results, events, or performance may differ
materially from the above forward-looking statements due to a
number of important factors, and will be dependent upon a variety
of factors, including, but not limited to, our ability to obtain
additional financing and access funds from our existing financing
arrangements that will allow us to continue our current and future
operations and whether demand for our products and services in
domestic and international markets will continue to expand. The
Company undertakes no obligation to publicly update these
forward-looking statements to reflect events or circumstances that
occur after the date hereof or to reflect any change in the
Company's expectations with regard to these forward-looking
statements or the occurrence of unanticipated events.
Contact: Amelot Holdings, Inc. 1(866)-669-8373
support@amelotholdings.com http://www.amelotholdings.com
HLK Biotech (CE) (USOTC:AMHD)
Historical Stock Chart
From Nov 2024 to Dec 2024
HLK Biotech (CE) (USOTC:AMHD)
Historical Stock Chart
From Dec 2023 to Dec 2024